Synchrotron Characterization of Hexagonal and Cubic Lipidic Phases Loaded with Azolate/Phosphane Gold(I) Compounds: A New Approach to the Uploading of Gold(I)-Based Drugs
Open Access
- 16 September 2020
- journal article
- research article
- Published by MDPI AG in Nanomaterials
- Vol. 10 (9), 1851
- https://doi.org/10.3390/nano10091851
Abstract
Gold(I) phosphane compounds have recently attracted a renewed interest as potential new protagonists in cancer therapy. A class of phosphane gold(I) complexes containing azolate ligands has been successfully tested against several cancer cell lines and, in particular, against basal-like breast (BLB) cancer, a form characterized by strongly severe diagnosis and short life lapse after classic chemotherapy. Even though the anticancer activity of gold(I) phosphane compounds is thoroughly ascertained, no study has been devoted to the possibility of their delivery in nanovectors. Herein, nonlamellar lyotropic liquid crystalline lipid nanosystems, a promising class of smart materials, have been used to encapsulate gold(I) azolate/phosphane complexes. In particular, ((triphenylphosphine)-gold(I)-(4,5-dichloroimidazolyl-1H-1yl)) (C-I) and ((triphenylphosphine)-gold(I)-(4,5-dicyanoimidazolyl-1H-1yl)) (C-II) have been encapsulated in three different lipid matrices: monoolein (GMO), phytantriol (PHYT) and dioleoyl-phosphatidylethanolamine (DOPE). An integrated experimental approach involving X-ray diffraction and UV resonant Raman (UVRR) spectroscopy, based on synchrotron light and attenuated total reflectance Fourier transform infrared (ATR-FTIR) spectroscopy, has been employed to establish the effects of drug encapsulation on the structure and phase behavior of the host mesophases. The results indicate that gold(I) complexes C-I and C-II are successfully encapsulated in the three lipid matrices as evidenced by the drug-induced phase transitions or by the changes in the mesophase lattice parameters observed in X-ray diffraction experiments and by the spectral changes occurring in UV resonant Raman spectra upon loading the lipid matrices with C-I and C-II.This publication has 39 references indexed in Scilit:
- Recent advances of non-lamellar lyotropic liquid crystalline nanoparticles in nanomedicineCurrent Opinion in Colloid & Interface Science, 2020
- Recent advancements in liposome technologyAdvanced Drug Delivery Reviews, 2020
- Updates on the use of liposomes for active tumor targeting in cancer therapyNanomedicine, 2020
- Encapsulation of vitamin B12 into nanoengineered capsules and soft matter nanosystems for targeted deliveryColloids and Surfaces B: Biointerfaces, 2019
- Nature‐Inspired Design and Application of Lipidic Lyotropic Liquid CrystalsAdvanced Materials, 2019
- Non-Lamellar Lyotropic Liquid Crystalline Lipid Nanoparticles for the Next Generation of NanomedicineACS Nano, 2019
- Cubosomes: The Next Generation of Smart Lipid Nanoparticles?Angewandte Chemie, 2018
- Advances in structural design of lipid-based nanoparticle carriers for delivery of macromolecular drugs, phytochemicals and anti-tumor agentsAdvances in Colloid and Interface Science, 2017
- Monoolein Cubic Phase Gels and Cubosomes Doped with Magnetic Nanoparticles–Hybrid Materials for Controlled Drug ReleaseACS Applied Materials & Interfaces, 2017
- Liposomes as ‘smart’ pharmaceutical nanocarriersSoft Matter, 2010